nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
American Society of Hematology: building a comprehensive minority recruitment and retention professional program
|
Rollins, Margo R. |
|
|
8 |
24 |
p. 6237-6247 |
artikel |
2 |
Cardiovascular toxicities associated with novel cellular immune therapies
|
Munir, Malak |
|
|
8 |
24 |
p. 6282-6296 |
artikel |
3 |
Celebrating a year of immunotherapy/cell and gene therapy in Blood Advances
|
Bollard, Catherine M. |
|
|
8 |
24 |
p. 6334-6336 |
artikel |
4 |
Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease
|
Jonassaint, Charles R. |
|
|
8 |
24 |
p. 6257-6266 |
artikel |
5 |
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies
|
Soulard, Margaux |
|
|
8 |
24 |
p. 6171-6182 |
artikel |
6 |
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes
|
Charalampopoulou, Stella |
|
|
8 |
24 |
p. 6297-6307 |
artikel |
7 |
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma
|
Tringale, Kathryn R. |
|
|
8 |
24 |
p. 6195-6206 |
artikel |
8 |
Guideline concordance of aspirin use for primary prevention in adult outpatients
|
Chipalkatti, Naina |
|
|
8 |
24 |
p. 6207-6214 |
artikel |
9 |
HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma
|
Chantziou, Amanda |
|
|
8 |
24 |
p. 6215-6231 |
artikel |
10 |
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia
|
Pal, Khushboo V. |
|
|
8 |
24 |
p. 6161-6170 |
artikel |
11 |
Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis
|
Andersen Jr., Michael |
|
|
8 |
24 |
p. 6151-6160 |
artikel |
12 |
Incidence of preexisting B-cell aplasia in B-ALL: implications for post–CAR T-cell monitoring
|
Sahai, Isha |
|
|
8 |
24 |
p. 6329-6333 |
artikel |
13 |
Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.
|
|
|
|
8 |
24 |
p. 6267 |
artikel |
14 |
Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.
|
|
|
|
8 |
24 |
p. 6232-6233 |
artikel |
15 |
Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration
|
Kostopoulos, Nektarios |
|
|
8 |
24 |
p. 6308-6320 |
artikel |
16 |
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy
|
Uy, Geoffrey L. |
|
|
8 |
24 |
p. 6248-6256 |
artikel |
17 |
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas
|
Arribas, Alberto J. |
|
|
8 |
24 |
p. 6268-6281 |
artikel |
18 |
Retreatment of multiple myeloma with previously refractory drugs
|
Goel, Utkarsh |
|
|
8 |
24 |
p. 6321-6328 |
artikel |
19 |
Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia
|
Schifferli, Alexandra |
|
|
8 |
24 |
p. 6183-6194 |
artikel |
20 |
Time to revisit reduced-dose radiotherapy for PCNSL?
|
Tatarczuch, Maciej |
|
|
8 |
24 |
p. 6234-6236 |
artikel |